BioVie Inc (BIVI) FinancialsBIVIBioVie Inc

Evaluating the bottom line, BioVie Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -151.06%, provide a clear picture of how effectively BIVI converts its operational activities into shareholder value.

In the context of the broader market, BIVI competes directly with industry leaders such as TCRX and GUTS. With a market capitalization of $11.63M, it holds a significant position in the sector. When comparing efficiency, BIVI's gross margin of N/A stands against TCRX's 100.00% and GUTS's N/A. Such benchmarking helps identify whether BioVie Inc is trading at a premium or discount relative to its financial performance.

BioVie has reported negative net income consistently, with the latest quarterly loss at $5,270,299. The current ratio has dropped to 3.59, indicating a decrease in liquidity. The forward P/E ratio is 0, showing no expected earnings growth in the near term.